Adaptive Biotechnologies Corp Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adaptive Biotechnologies Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $44K, a 93.5% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.25M, a 98.3% decline from 2022.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $132M, a 387% increase from 2021.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $27.1M, a 90.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.25M -$130M -98.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $132M +$105M +387% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $27.1M -$266M -90.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $294M -$26.3M -8.23% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $320M +$319M +25534% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $1.25M -$48.8M -97.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $50M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.